法国 思塔高 stago     
Satgo成立于1945年，从药物分析起家，现成为体外诊断（IVD）行业中致力于血栓与止血研究的专业公司。

公司一览
通过研发、生产到物流保障、市场、销售以及国际拓展，Stago从全方位确保公司整体战略的实施。

通过了ISO13485和ISO9001（2008）认证，Stago绝大部分的工业生产都集中在法国。而全球化发展也驱使我们将产品的研发及制造中心延伸至美国、荷兰、德国和爱尔兰。我们对于产品研发的投资远大于IVD行业的平均投入。

自从1985年美国分公司成立以来，Stago的直销网络一直在发展。在过去的10年间，我们又陆续成立了5间分公司，它们分别是：Stago中国（2003），Stago英国（2005），拓展中东业务的Stago迪拜办事处（2007），Stago澳大利亚/新西兰以及Stago加拿大（2008）。

Stago旗下的公司有：Stago, Tcoag, Agrio-Bio, BioCytex, Thrombinoscope, Synapse 和 DSRV。

里程碑
Stago是由Jacques Viret（卒于2009年10月）先生在第二次世界大战末期创立，销售一种用于缓解消化和肝功能障碍的药物，到今天Stago已经发展到拥有近2000名雇员，其中超过一半在法国工作。

With a staff close to 1,500 and the most advanced technologies, Diagnostica Stago formulates, manufactures and markets worldwide, the broadest range of reagents and analytical instruments in haemostasis. Diagnostica Stago devotes its research and innovative skills to the development of increasingly effective medical diagnostic products and instrumentation.

Because we are committed to a better understanding of haemostasis and thrombosis, Diagnostica Stago's creativity, supported by a team of specialized researchers, results in a range of reagents and instruments which just keeps getting better. This involves constant leading-edge research as well as the improvement of existing kits.

Selected distributors and international marketing support
Thanks to a wide international network of distributors, Diagnostica Stago is represented in more than 110 countries. Without exception, each distributor is chosen according to strict criteria regarding the performance of its team, its capabilities in after-sales services, and its commitment to knowing and promoting the Diagnostica Stago line. For the last few years, our efforts have focused primarily on the individual needs of each country and each market, taking into account their specific expectations. This is effective because of the local field activity of the sales and marketing export team.

Flexible production
Faced with a diverse and ever-increasing demand, Diagnostica Stago is finding ways of closely monitoring the evolution of markets and forecasting their development. The flexibility of our production capabilities and the proficiency of our logistics division have enabled us to respond effectively to the needs of our partners and international clients.

Your partner for the diagnosis of coagulation and thrombosis
For a long time, Diagnostica Stago has maintained a partnership with many hospital and research laboratories working on thromboembolic diseases, and blood transfusion centres. Diagnostica Stago products have a clinical application in diagnosis, in the treatment of haemostasis disorders (haemophilia, thrombosis) and in the prediction of thromboembolic risk. By the way, the assessment of thrombosis which represents one of the priorities of Diagnostica Stago is considered by the experts as the future of haemostasis.
 

Key date of STAGO's development
 

1945: Creation of Laboratoire Stago, Paris, France
1962: Stago develops its first test reagents for coagulation
1976: Stago dedicates itself exclusively to coagulation testing and becomes Diagnostica Stago
1979: Creation of the Reagent Research and Development Centre
1985: Establishment of an American subsidiary
1987: Creation of the Instrumentation Division
1992: Worldwide launch of STA®, the first fully automated coagulation analyser
2000: Addition of a new production facility in Taverny (France)
2003: Establishment of a Chinese subsidiary
2005: Establishment of an United Kingdom subsidiary
2007: Diagnostica Stago changes its logo
2008: Establishment of a AUE (Dubaï) subsidiary